Option Care Health, Inc. (OPCH) stock analysis
Close on Nov 11, 2026Market cap $4.75BP/E 23.8Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Solid15 of 30 checks passed
Option Care Health passes 15 of the 30 checks behind our score; 7 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 4/6
- Growth
- 3/6
- Past performance
- 3/6
- Financial health
- 5/6
- Dividend
- 0/6
What stands out
Trading below fair value
The share price of $31.70 is below our fair value estimate of $32.79.
Return on capital over 10%
Return on invested capital was 10.9%, above the 10% that usually covers the cost of capital.
Revenue growing 10%+ a year
Revenue grew 12.7% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 15.2% a year over the last three fiscal years.
What to watch
Margin of safety under 20%
The price is 3.3% below fair value, less than the 20% cushion we look for.
Return on equity under 15%
Return on equity was 16.0% over the last twelve months and averaged 14.7% over five years; we look for 15% on both.
High debt
Debt is 92.0% of shareholders' equity, above the 40% we consider low.
P/B above the industry
Option Care Health's price-to-book of 3.77 is above the Health Services median of 3.52.
Valuation4/6
P/E below its 5-year median
Option Care Health's P/E of 23.8 is below its own 5-year median of 25.7.
P/E below the industry
Option Care Health's P/E of 23.8 is below the Health Services median of 23.9.
EV/EBITDA below its 5-year median
Option Care Health's EV/EBITDA of 14.2 is below its 5-year median of 16.6.
P/B above the industry
Option Care Health's price-to-book of 3.77 is above the Health Services median of 3.52.
Trading below fair value
The share price of $31.70 is below our fair value estimate of $32.79.
Margin of safety under 20%
The price is 3.3% below fair value, less than the 20% cushion we look for.
Growth3/6
Revenue growing 10%+ a year
Revenue grew 12.7% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 15.2% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 5.9% over the last twelve months; the Health Services median is 9.1%.
Guidance raised
Option Care Health raised its full year 2026 Adjusted diluted earnings per share outlook on Jul 29, 2026.
Gross margin slipping
Gross margin was 19.1% over the last twelve months, against 19.7% a year earlier.
Past performance3/6
Return on equity under 15%
Return on equity was 16.0% over the last twelve months and averaged 14.7% over five years; we look for 15% on both.
Return on capital over 10%
Return on invested capital was 10.9%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Option Care Health's return on equity of 16.0% is above the Health Services median of 4.6%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin below its 5-year average
Net margin was 3.7% over the last twelve months, against a 5-year average of 4.4%.
Net margin above the industry
Option Care Health's net margin of 3.7% is above the Health Services median of -2.6%.
Financial health5/6
High debt
Debt is 92.0% of shareholders' equity, above the 40% we consider low.
Debt falling against equity
Debt to equity fell from 111% five years ago to 92.0%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 29.9% of total debt.
Interest well covered
Operating income covers interest expense 6.2 times.
Short-term assets cover short-term debts
Current assets are 1.47 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 3.90; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Option Care Health has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$32.79
The share price is 3% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 24.8× | 25.7× | 23.9× | $33.01 | 40% |
| EV/EBITDA | 16.4× | 16.6× | 16.2× | $37.48 | 35% |
| P/B | 3.7× | 3.9× | 3.5× | $31.01 | 10% |
| Earnings power | 8.3% cost of equity | – | – | $22.48 | 15% |
| Fair value | $32.79 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 25.7
- Health Services median 23.9
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $197.17M
- Value traded per 1% price move
- $66.05M
Downside
High risk
- Typical loss in a bad month
- 29.7%
- Volatility (annualized)
- 52%
- Sharpe ratio, 1 year
- 0.16
- Beta to the S&P 500 (5Y)
- 0.68
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +13.0% | +12.7% | +13.3% | – | |
| Gross profit | +7.4% | +7.9% | +9.8% | +15.4% | |
| Operating income | +5.0% | +12.0% | +25.0% | – | |
| Net income | -2.0% | +11.3% | – | – | |
| EPS, diluted | +3.3% | +15.2% | – | – | |
| Free cash flow | -24.5% | -2.2% | +16.7% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -16.5% | -0.8% | 15.2% | |
| Return on assets | -7.5% | -0.3% | 6.0% | |
| Current ratio | 1.33 | 1.51 | 1.53 | |
| Debt to equity | 0.75 | 1.11 | 0.88 | |
| Net debt to EBITDA | 36.89× | 5.63× | 2.29× | |
| Interest coverage | – | 1.0× | 6.2× | |
| Inventory turnover | 17.0× | 17.1× | 10.6× | |
| Capex to revenue | – | 0.9% | 0.7% | |
| Diluted shares | 105M | 181M | 163M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Option Care Health generated $1.43B from operations and spent $992.71M on capital expenditure, dividends and share buybacks. 18% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 3.7% | 1.64× | 2.52× | 15.2% |
| FY2024 | 4.2% | 1.51× | 2.35× | 15.0% |
| FY2023 | 6.2% | 1.36× | 2.25× | 19.0% |
| FY2022 | 3.8% | 1.34× | 2.30× | 11.8% |
| FY2021 | 4.1% | 1.26× | 2.48× | 12.8% |
| FY2020 | -0.3% | 1.16× | 2.72× | -0.8% |
| FY2019 | -3.3% | 1.15× | 2.66× | -10.1% |
| FY2018 | -0.3% | 1.91× | 1.68× | -1.0% |
| FY2017 | 0.2% | 3.03× | 1.00× | 0.6% |
| FY2016 | -4.6% | 1.65× | 2.19× | -16.5% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$207.59M
- Cash generatingOperating cash flow above zero$258.45M
- Return on assets improvedROA up on the prior year6.6% → 6.1%
- Earnings backed by cashOperating cash flow above net income$258.45M vs $207.59M
- Less leverageLong-term debt to assets fell32.3% → 33.4%
- Better liquidityCurrent ratio rose1.70 → 1.53
- No dilutionShare count did not rise173M → 163M
- Gross margin improvedGross margin up on the prior year20.27% → 19.26%
- More efficientAsset turnover rose1.55 → 1.65
See a number that looks wrong?